Discontinued — last reported Q4 '20

Other

Finance Lease Principal Paid

Vertex Pharmaceuticals Finance Lease Principal Paid remained flat by 0.0% to $1.35M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 83.9%, from $8.40M to $1.35M. Over 2 years (FY 2023 to FY 2025), Finance Lease Principal Paid shows a downward trend with a -65.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementIncome Statement
SectionOther
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ1 2019
Last reportedQ4 2020

How to read this metric

An increase indicates active deleveraging of lease-related debt, while a decrease may signal new lease acquisitions or slower repayment.

Detailed definition

This represents the cash outflow used to reduce the principal balance of finance lease liabilities. It indicates the rat...

Peer comparison

Commonly reported in the financing section of the cash flow statement for companies with significant leased assets.

Metric ID: is_cvx_finance_lease_principal_paid

Historical Data

3 years
 FY'23FY'24FY'25
Value$44.90M$33.60M$5.40M
YoY Change-25.2%-83.9%
Range$5.40M$44.90M
CAGR-65.3%
Avg YoY Growth-54.5%
Median YoY Growth-54.5%
Current Streak2+ years decline

Frequently Asked Questions

What is Vertex Pharmaceuticals's finance lease principal paid?
Vertex Pharmaceuticals (VRTX) reported finance lease principal paid of $1.35M in Q4 2025.
How has Vertex Pharmaceuticals's finance lease principal paid changed year-over-year?
Vertex Pharmaceuticals's finance lease principal paid decreased by 83.9% year-over-year, from $8.40M to $1.35M.
What is the long-term trend for Vertex Pharmaceuticals's finance lease principal paid?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's finance lease principal paid has grown at a -65.3% compound annual growth rate (CAGR), from $44.90M to $5.40M.
What does finance lease principal paid mean?
The principal repayment portion of finance lease obligations.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.